TMS may help some Wisconsin residents with depression when other treatments fall short; response means substantial improvement, while remission means minimal symptoms.
Does TMS Work? An Honest Guide to Response and Remission in Wisconsin
Transcranial magnetic stimulation (TMS) can help some people with depression, particularly when medication, talking therapy or both have not brought enough improvement. It is not a guaranteed treatment, and results vary from person to person.
For people considering TMS in Wisconsin, it can be useful to understand the terms clinicians use when discussing outcomes. Two of the most important are response and remission. They are related, but they do not mean the same thing.
TMS Therapy Wisconsin lists 47 published clinics across the state. Options are listed in and around Milwaukee, Waukesha, Wauwatosa, Middleton, West Allis, Glendale, Brookfield and other communities, including Appleton, Racine, Wausau, Kenosha and Mequon. Availability does not answer whether TMS will work for an individual, but it may make it easier to explore an assessment close to home.
What does “response” mean?
In depression treatment, a response usually means that symptoms have improved substantially compared with the start of treatment.
This is normally measured using a recognised depression questionnaire, alongside clinical discussion. A person may report fewer days of low mood, less hopelessness, better concentration, more motivation, improved sleep or a greater ability to manage work, relationships and daily tasks.
A response does not necessarily mean that all symptoms have gone. Someone may still have depression, but feel noticeably better and function more consistently than they did before treatment.
For example, a person who had been struggling to get out of bed, attend work or speak to friends may begin doing some of those things again. They may still have difficult days, but the overall pattern has shifted.
Response matters because partial improvement can still be meaningful. It may help someone re-engage with therapy, exercise, social support, medication management or other parts of their care plan.
What does “remission” mean?
Remission means that depressive symptoms have reduced to a very low level, or are no longer causing significant day-to-day difficulty.
It does not always mean a person will never experience depression again. Depression can recur, and some people need ongoing support after they finish a course of TMS. However, remission generally describes a period in which symptoms are minimal and the person is functioning well.
The difference can be thought of simply:
- Response: “I am clearly better than I was.”
- Remission: “My symptoms are now minimal or no longer significantly affecting my life.”
Clinicians may use scores from depression rating scales to define these terms. They should also ask about the person’s own experience. A questionnaire score is helpful, but it cannot fully capture whether someone feels able to parent, work, study, sleep, enjoy relationships or feel like themselves again.
What do published TMS trials generally show?
Published clinical trials and later real-world studies support TMS as an effective option for some adults with major depressive disorder, especially those whose depression has not improved sufficiently with previous treatment.
The results are encouraging, but they are not uniform. Across studies, some participants experience a substantial reduction in symptoms, some reach remission, some improve only partly, and some do not notice a meaningful benefit from a course of treatment.
This is one reason to be cautious with simple success-rate claims. Different studies may include different groups of patients, use different TMS protocols, measure outcomes in different ways and assess people at different points in time. A study involving people with long-standing, treatment-resistant depression may show different results from one involving people earlier in their treatment journey.
It is also important to distinguish between a trial result and an individual prediction. Research can describe what happened in groups of people. It cannot reliably tell one particular Wisconsin patient in advance whether they will respond or remit.
TMS received US Food and Drug Administration clearance for major depressive disorder in 2008. In 2021, FDA clearance also covered depression with comorbid anxiety. Clearance means the treatment has met the relevant regulatory standard for its intended use; it does not mean it will be equally effective for every person.
Why do individual results vary?
Depression is not one single condition with one single cause. Its severity, duration and symptoms differ widely between people. So do the factors that may affect treatment outcome.
A person’s response to TMS may be influenced by:
- how long their current depressive episode has lasted;
- the severity of symptoms at the start of treatment;
- previous response to medication, therapy or other treatments;
- co-occurring anxiety, trauma symptoms, substance use, chronic pain or other health conditions;
- sleep, stress, housing, work and family circumstances;
- whether treatment sessions can be attended consistently;
- the specific TMS protocol and clinical plan used.
None of these factors alone can determine the outcome. They are part of a broader clinical picture.
TMS is usually delivered as a course of weekday appointments over roughly six to nine weeks, often around 36 sessions. Improvement may be gradual. Some people notice changes during the course, while others report clearer benefits towards the end or after treatment has finished. A lack of immediate change does not necessarily mean the treatment will not help, but progress should be reviewed regularly with the treating clinician.
The importance of a proper assessment
Before beginning TMS, a clinician should review the person’s diagnosis, treatment history, current symptoms, medications and relevant medical history. They should also discuss whether TMS is appropriate and what alternatives may be available.
This assessment is especially important where there are symptoms of bipolar disorder, psychosis, active substance dependence, significant neurological history or immediate safety concerns. TMS may still be considered in some circumstances, but the decision needs individual clinical judgement.
People should also be able to ask practical questions, including:
- What symptoms will be tracked during treatment?
- How will response and remission be assessed?
- What happens if I improve only partly?
- What support is available if symptoms worsen?
- Will I continue medication or therapy during TMS?
- What is the plan after the course ends?
A thoughtful clinic should not promise remission. It should explain potential benefits and limitations clearly, and monitor how the person is doing throughout treatment.
Side effects and realistic expectations
TMS is non-invasive and does not require surgery. The most common side effects are scalp discomfort during treatment and headache afterwards. These are often manageable, though they can be unpleasant for some people.
Seizure is a rare risk. A clinic should discuss safety screening and any factors that may affect suitability before treatment begins.
For many people, the realistic question is not simply “Does TMS work?” but “Is TMS a reasonable next treatment to discuss in my circumstances?” That discussion should take account of depression severity, previous treatment, daily responsibilities, travel to appointments and the person’s own goals.
Insurance and access in Wisconsin
Insurance coverage for TMS depends on the individual plan, clinical criteria, prior treatment history and the provider’s arrangements. Plans commonly seen in Wisconsin include Anthem Blue Cross and Blue Shield (Wisconsin), Quartz Health Solutions, Dean Health Plan, Security Health Plan, UnitedHealthcare, Cigna, Aetna and BadgerCare Plus (Wisconsin Medicaid).
Before arranging treatment, ask both the clinic and insurer about prior authorisation, documentation requirements, network status and possible out-of-pocket costs. Coverage rules can change, so confirmation from the insurer is important.
Getting help in Wisconsin
Use the TMS Therapy Wisconsin clinic listings to find published providers across the state, including listings in the Milwaukee area and other Wisconsin communities. The directory’s insurance guide may help you prepare questions for your plan, and the contact page can help with general directory enquiries.
This article is educational information, not medical advice.
This page is informational and is not medical advice.